YG

Yogesh Ganesh Sonune

Active Director Director DIN 11645608
DIN 11645608 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Yogesh Ganesh Sonune

Data last updated:

Yogesh Ganesh Sonune is a Director at Newsupa Biotech Private Limited (since 2026).

DIN 11645608
Primary Designation Director
First Appointment 02 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Newsupa Biotech Private Limited U46692ME2026PTC474246
Director02 Apr 20262026Active

Board colleagues of Yogesh Ganesh Sonune

NameDINCompanyDesignation
Arun Ganesh Sonune11029736Newsupa Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Newsupa Biotech Private Limited
Premium access

Shareholding and investment profile for Yogesh Ganesh Sonune

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Ganesh Sonune

Yogesh Ganesh Sonune currently holds 1 directorship: Newsupa Biotech Private Limited (Director, since 02 Apr 2026).

Yogesh Ganesh Sonune was first appointed on 02 Apr 2026 as Director at Newsupa Biotech Private Limited.

The current boards of Yogesh Ganesh Sonune's companies include Arun Ganesh Sonune (Newsupa Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available